JUPITER NEUROSCIENCES INC

Insider buying surges at Jupiter, signaling confidence in its resveratrol therapy pipeline and potential share price rally—yet high biotech risk remains.

Insider executives buy massive options in Jupiter; confidence rises amid steep share decline—could signal breakthrough in neuro‑inflammation therapy.